At this year’s Concordia Summit, conversations about innovation spanned technology, health and the future of work. Among them was a discussion centered on the most vital form of infrastructure we have yet to fully invest in: the human brain.
In a session titled “Inside the Brain Revolution: Health, Longevity and Market Potential,” experts in neuroscience, investment and technology explored how breakthroughs in brain science could reshape healthcare, resilience and economic productivity. Vitanya participated in that dialogue, sharing insights from our brain performance optimization program, which enhances focus, recovery and decision-making in high-stress fields.
The takeaway was clear: The next great frontier of innovation isn’t artificial. It’s profoundly human.
Across industries, the same pattern is emerging. Productivity is stagnating even as innovation accelerates. Leaders see rising anxiety, chronic stress, depression, absenteeism and sleeplessness — invisible taxes on growth that are eroding the very capacity that technology was meant to enhance. Despite record investment in efficiency tools, the human systems that run them are depleted. The real constraint on growth is capacity itself.
That gap is measurable and investable. Global investment in neurotechnology and brain health is accelerating, with $2.3 billion in neurotech funding in 2024 and a broader mental-health market exceeding $400 billion. Funds such as HEKA BrainTech Fund, PsyMed Ventures and Brain Capital Partners are defining brain capital as a legitimate investment category, while initiatives like the Center for BrainHealth at UT Dallas are creating standardized ways to measure cognitive resilience at scale. It’s clear that strengthening cognitive capacity is no longer just a wellness initiative but a serious economic advantage.
Brain capital: The next evolution of human capital
Sustained improvements in anxiety, depression, stress regulation and sleep translate directly into measurable gains in productivity, retention and safety. When achieved at scale, they create a new category of value: brain capital.
For decades, organizations have mastered risk modeling yet largely ignored resilience. Brain capital corrects that imbalance. It forms the foundation of performance and innovation, enabling people and institutions to stay agile, collaborative and purpose-driven in a world of constant disruption.
The encouraging news is that the capacity problem can be solved. In our work at Vitanya, we are pioneering neurotechnology solutions to strengthen focus, resilience and human capacity. A new generation of technology-enabled programs including neurofeedback, biofeedback and adaptive AI are helping people retrain the brain to recover from stress and build new patterns of focus and control. Vitanya translates a neurotechnology use case into real-time outcomes for high-stakes sectors like law enforcement and first responders, with clinical-grade improvements in sleep, recovery and reaction time directly impacting human and organizational performance.
From the barracks to the boardroom, these approaches are optimizing decision-making, recovery and emotional regulation — the human metrics that define sustainable productivity and growth. As AI automates the routine and the analytical, uniquely human capacities such as empathy, creativity and complex judgment define a new edge of competitive intelligence.
Using the digital world to make the real world better
Technology was meant to simplify life, expand connection and reduce strain. Instead, it fractures attention and intensifies stress. Yet the same systems that overwhelm us now hold the key to our recovery. Through neurotechnology, we can translate complex brain science into everyday practices for recovery and focus. This is technology for good, designed to serve human purpose, not replace it.
This is what we mean at Vitanya by democratizing resilience: making upstream tools accessible to everyone, not just a privileged few. When resilience becomes accessible at scale, the returns ripple outward in the form of lower burnout, higher engagement, greater innovation and stronger economies.
A new direction for impact investing
The rehumanization economy is emerging, one that treats human capacity not as a cost to manage but as capital to cultivate. The next undervalued asset lies in the brain itself.
As capital continues to flow toward AI, investors have a parallel opportunity to back the science and systems that restore the capacity eroded by technology. Advances in neuroscience and adaptive AI now make it possible to strengthen and measure resilience at scale, democratizing access to brain health across workforces and communities.
The productivity crisis is human, and so is the solution. This is the rehumanization economy, setting human flourishing as the ultimate growth metric. Investors who see that first will define the next age of opportunity.
Michael Southworth is the CEO of Vitanya Brain Performance.
Guest posts on ImpactAlpha represent the opinions of their authors and do not necessarily reflect the views of ImpactAlpha.
